Regorafenib in Glioblastoma Recurrence: How to Deal With MR Imaging Treatments Changes

Regorafenib in Glioblastoma Recurrence: How to Deal With MR Imaging Treatments Changes

The treatment of recurrent high-grade gliomas remains a major challenge of daily neuro-oncology practice, and imaging findings of new therapies may be challenging. Regorafenib is a multi-kinase inhibitor that has recently been introduced into clinical practice to treat recurrent glioblastoma, bringi...

Full description

Bibliographic Details
Main Authors: Simona Gaudino, Giammaria Marziali, Carolina Giordano, Riccardo Gigli, Giuseppe Varcasia, Francesca Magnani, Silvia Chiesa, Mario Balducci, Alessandro Maria Costantini, Giuseppe Maria Della Pepa, Alessandro Olivi, Rosellina Russo, Cesare Colosimo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Radiology
Subjects:
regorafenib
glioblastoma
MRI
treatment changes
imaging
Online Access:https://www.frontiersin.org/articles/10.3389/fradi.2021.790456/full

Internet

https://www.frontiersin.org/articles/10.3389/fradi.2021.790456/full

Similar Items